Skip to main content

Failure to tackle drug-resistant infections will lead to at least 10 million extra deaths a year and cost the global economy up to $100 trillion (£64 trillion) by 2050

Jim O'Neill, former Goldman Sachs chief economist and Chairman of the Review on AMR


Find out how researchers at the Centre for Antimicrobial Resistance at the University of Dundee are delivering innovation in antimicrobial research, translation and clinical practice.

Latest Events

No Upcoming Events